Power Law company profile

Enanta Pharmaceuticals

Biotech & Life Sciences · Watertown, United States · Founded 1998 · IPO 2013 Thoroughbred

Enanta Pharmaceuticals, Inc

Valuation

$274M

Market cap · May/2026

Revenue

$65M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

7 investors on Enanta Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Techno Venture Management

Series B+ 6 investors entered at this stage

NIBC Bank

Yasuda Enterprise Development

Bioventures Investors

Thuja Capital

Advent International

Oxford Bioscience Partners

Global footprint

Where Enanta Pharmaceuticals has talent and traffic

Workforce by country

5 countries with
team presence

🇺🇸 United States98%

🇬🇧 United Kingdom1%

🇮🇳 India0.9%

🇪🇸 Spain0.9%

🇧🇬 Bulgaria0.9%

5 countries shown

Web traffic by country

3.3K monthly visits
across markets

🇺🇸 United States69.7%

🇮🇳 India30.3%

Top 2 markets shown

Market sentiment

What the market is saying about Enanta Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Enanta Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Enanta Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles